
Weight-Loss Jabs Are in SA Gyms. Set Your Rules Now
In October the chair of South Africa's drugmakers' body named gym instructors among the people selling an unapproved obesity drug. Legal use is climbing at the same time. You need one rule for your staff and a different plan for the members on these medicines.
Weight-loss jabs are now a floor problem for South African gyms as well as a medical one. In mid-October Stavros Nicolaou, who chairs the Pharmaceutical Task Group, told Business Day that retatrutide, an experimental Eli Lilly drug no medicines regulator has declared safe and effective, is being sold "openly and brazenly" in South Africa by social media influencers, gym instructors and hairdressers. The report gives no count, and Nicolaou is also a senior executive at Aspen, which distributes the legal competitor Mounjaro. You still need an answer ready for the day one of your coaches is the instructor in question.
Legal use is climbing too. Claims paid to Discovery Health Medical Scheme members for GLP-1 medicines rose from 22 400 in 2022 to 61 200 in 2025, Vitality's Mosima Mabunda told Business Day, and she said that undercounts use because many people pay out of pocket. Briefly News, reporting from an industry roundtable in Pretoria on 14 October, cites an estimate of about 230 000 users nationally. These medicines are only available in the private sector, so some of those users are probably on your debit-order list.
The market
Why weight-loss jabs will reach more of your members
Novo Nordisk's South African patent on semaglutide, the ingredient in Ozempic and Wegovy, expired this year. Sun Pharma launched the first generic, Semagard, in August at about 18,5% below Ozempic, according to the Bhekisisa Centre for Health Journalism, which also reports that the regulator, SAHPRA, is considering 13 more applications. Novo answered with its own lower-priced copy, Extensior.
Ozempic
Extensior
Those are the regulated single exit prices Business Day reported on 24 July, VAT included. A 15% cut is real money for someone already paying and small against most household budgets, and Discovery Health said it was unlikely to justify broader scheme funding. So this is a slow change rather than a flood. Mabunda still expects the number of users to rise significantly as cheaper generics arrive. On 28 October Business Day reported that the health department has not started assessing these medicines for obesity care in the public sector, which keeps demand concentrated among people who can pay, the same people who can pay you.
The gap
What the medicine leaves for a gym to do
The same Discovery release cites research that around two-thirds of the weight lost may come back within a year of stopping treatment. Its answer is a programme built around the medicine, Vitality HealthyWeight, and the World Health Organization points the same way. Its December 2025 guideline says structured diet and physical activity support may be offered to adults prescribed these medicines, while grading the evidence behind that advice as low certainty.
Muscle is where a gym has the most to offer. In a 140-person sub-study of the STEP 1 trial, adults on semaglutide lost 15,0% of their body weight over 68 weeks. Total fat mass fell 19,3% and lean body mass fell 9,7%. Lean mass includes more than muscle, and it fell by less than fat, so its share of the body went up. Some of it still went.
Don't assume these members will find you on their own. Three American data points, none of them South African, show why:
- PwC's May 2026 survey found 21% of current users had increased strength training, 17% had cut back and 41% had never done it.
- William Blair's 2026 survey of 300 users put gym membership at about 35% after starting treatment, up only three percentage points.
- Athletech News reported on 753 adults in the National Institutes of Health's All of Us programme, whose Fitbit data showed daily steps falling from 5 047 to 4 487 after they started.
Be careful what you promise. Trials of resistance training alongside these medicines are still running, including LEAN-PREP, a 232-person study whose protocol appeared in BMJ Open in April 2026. Selling strength work as sensible training for someone losing weight is fair. Advertising that it protects muscle on a named drug goes further than the evidence, and Briefly News reports that South African law bans advertising prescription medicines on social media. Keep brand names out of your marketing altogether.
Nobody on your floor sells, sources, stores or injects. Everybody on your floor can coach.
This week
Five things to settle before the January intake
Ban sales in writing, for everyone on the floor
Add one clause to staff contracts and to the agreement with any contract trainer: nobody sells, sources, stores or injects weight-loss medicine on your premises. Authorities at the October roundtable told consumers to get these medicines only through a licensed healthcare professional and a registered pharmacy. SAHPRA has seized products and opened criminal dockets, Briefly News reports. If you find it happening, take legal advice on the staff side and report the supply to SAHPRA on 0800 204 307.
Give coaches one line for medicine questions
"That's one for your doctor or pharmacist." It covers which product, what dose, where to buy, and whether to stop. If a member feels unwell during a session, the coach ends the session and points them to their doctor.
Ask about medication only with consent
Health information is special personal information under POPIA. Section 26 prohibits processing it, consent is the section 27 exception that fits a gym, and the health-specific authorisation in section 32 names bodies such as medical professionals and medical schemes, not gyms. Make any medication question optional, say why you ask and who will see the answer, and keep answers out of coach WhatsApp groups. Check your existing health questionnaire against the same test.
Offer a first strength block to anyone who has never lifted
WHO's activity guidelines ask adults for muscle-strengthening work on two or more days a week, so two coached full-body sessions a week is a defensible start. Open it to every beginner, with no drug name on it. Nobody has to disclose anything to join, which also removes the awkward question from step three.
Look at every member's attendance around month six
You won't know who is on what, and you don't need to. Have someone phone any member whose visits have dropped against their own pattern, and talk about training, not weight or medicine. It works for every member, including the ones on a GLP-1 who have just stopped claiming.
The point
Train the member. Leave the medicine to the doctor.
A coach can plan strength work, watch how a session goes and keep someone coming back after the prescription ends. A coach cannot recommend a drug, a dose or a supplier, or tell anyone to stop. Most of what a gym needs here is that line, written down and said out loud.
Add the clause in step one this week, and read it out at your next staff meeting.
If you are on the Vitality Fitness network, watch one detail. Discovery says Group Risk members on the HealthyWeight medicated pathway can earn up to 10 000 Discovery Miles a month by hitting their Vitality Active Rewards goals, so some will have a financial reason to keep moving. The market will keep shifting as well. Briefly News reports that the South African Pharmacy Council's revised compounding standards are expected in March 2027, so look at this again then. None of this is medical or legal advice: send medicine questions to a doctor or pharmacist, and contract questions to your attorney.
Flagging a member whose attendance has dropped against their own pattern, then prompting a person to call them, is part of the system we build into a gym.
Book a call